Dow futures jump 400 points, rebound from Friday's rout after yet another Trump U-turn
The Dow futures are trading with gains of over 420 points as the futures market opened on Sunday evening.
Dow Futures Surge As Trump Comments Allay China Fears
U.S. stocks looked set to rebound after President Donald Trump softened his tone on China, reassuring investors after his renewed tariff threats on Friday sent the market tumbling.
Futures tracking the Dow Jones Industrial Average climbed 455 points, or 1%. S&P 500 futures jumped 1.4%,
» Read more about: Dow Futures Surge As Trump Comments Allay China Fears »
Read MoreFive Retirement Planning Traps You Can't Afford to Fall Into, From a Wealth Adviser
Retirement is one of life’s biggest milestones, and preparing for it requires foresight, discipline and adaptability. Yet many individuals fall into avoidable traps that can jeopardize their financial security.
In fact, nearly half of Americans expect to retire with less than $500,000, according to the Schroders 2025 U.S.
Read MoreSilver prices surge in India amid record demand and ETF premiums
Silver prices in India have reached all-time high levels, driven by robust domestic demand, constrained supply, and global market factors. Physical silver is trading at ₹185 per gram and ₹1,85,000 per kilogram, reflecting a steep premium over international benchmarks.
Global spot silver prices surged to around $50 per ounce in early October amid renewed safe-haven buying and heightened investor interest.
» Read more about: Silver prices surge in India amid record demand and ETF premiums »
Read MoreInteractive Brokers: A Super Stock That Still Looks Super Attractive
16.72K Followers
With AI-driven Robo-Analyst technology, we help investors make smarter decisions based on proven-superior fundamental data,
» Read more about: Interactive Brokers: A Super Stock That Still Looks Super Attractive »
Read MoreThe Burst
Massive Upside In Big Money Pharma Favorite?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes in the use of immune therapies for cancer treatment. Specifically, Iovance is exploring new applications of tumor infiltrating lymphocyte (TIL) therapy, utilizing cells that the human body naturally produces to attack cancerous tumors.
There was lots of hype about this next-generation cancer treatment company but its share price has been decidedly lackluster this year,
» Read more about: Massive Upside In Big Money Pharma Favorite? »
Read MoreThe Ivy
This Airline Just Made a Huge Change, Will It Pay Off for Investors?
Southwest Airlines (NYSE:LUV) is one of America’s major air transportation companies. Recently, under pressure to deliver improved value for shareholders and renewed growth, the company announced a slate of changes that could, if successful, increase both its top and bottom lines in the years to come.
Today, let’s take a look at Southwest Airlines to see if LUV is a buy,
» Read more about: This Airline Just Made a Huge Change, Will It Pay Off for Investors? »
Read MoreThe Spotlight
1 Dividend Aristocrat To Be Wary Of
Residential real estate investment trust (REIT) Essex Property Trust, Inc. (NYSE:ESS) operates in West Coast markets, primarily acquiring, developing, and managing multifamily residential properties. It has a portfolio of more than 60,000 apartment units, primarily located in California and Seattle.
Founded in 1971 and going public in 1994,